
    
      OBJECTIVES:

        -  Examine the incidence of renal dysfunction in children and young adults being treated
           for acute lymphoblastic leukemia with low- to intermediate-dose methotrexate.

      OUTLINE: Medical charts are reviewed to obtain the following information: gender, age,
      diagnosis, regimen, day of therapy, renal function, creatinine level, mucositis, skin
      sloughing, methotrexate level at highest level, and number of days after intravenous
      methotrexate.
    
  